US 12195439
C1-substituted isopropylamine fused heterocyclic mescaline derivatives
granted A61PA61P25/00
Quick answer
US patent 12195439 (C1-substituted isopropylamine fused heterocyclic mescaline derivatives) held by Enveric Biosciences Canada Inc. expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enveric Biosciences Canada Inc.
- Grant date
- Tue Jan 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P25/00